KEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCASTRO, Gilberto de
dc.contributor.authorKUDABA, Iveta
dc.contributor.authorWU, Yi-Long
dc.contributor.authorLOPES, Gilberto
dc.contributor.authorKOWALSKI, Dariusz M.
dc.contributor.authorTURNA, Hande Z.
dc.contributor.authorCAGLEVIC, Christian
dc.contributor.authorZHANG, Li
dc.contributor.authorKARASZEWSKA, Boguslawa
dc.contributor.authorLAKTIONOV, Konstantin K.
dc.contributor.authorSRIMUNINNIMIT, Vichien
dc.contributor.authorBONDARENKO, Igor
dc.contributor.authorKUBOTA, Kaoru
dc.contributor.authorMUKHERJEE, Rinee
dc.contributor.authorLIN, Jianxin
dc.contributor.authorSOUZA, Fabricio
dc.contributor.authorMOK, Tony S. K.
dc.contributor.authorCHO, Byoung Chul
dc.date.accessioned2022-07-22T13:00:44Z
dc.date.available2022-07-22T13:00:44Z
dc.date.issued2021
dc.description.indexMEDLINEeng
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
dc.identifier.citationJOURNAL FOR IMMUNOTHERAPY OF CANCER, v.9, suppl.2, p.A390-A390, 2021
dc.identifier.doi10.1136/jitc-2021-SITC2021.363
dc.identifier.eissn2051-1426
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/47622
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUPeng
dc.relation.ispartofJournal for Immunotherapy of Cancer
dc.rightsopenAccesseng
dc.rights.holderCopyright BMJ PUBLISHING GROUPeng
dc.subject.wosOncologyeng
dc.subject.wosImmunologyeng
dc.titleKEYNOTE-042 5-YEAR SURVIVAL UPDATE: PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED, PD-L1POSITIVE, LOCALLY ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCEReng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryCoréia do Sul
hcfmusp.affiliation.countryLetônia
hcfmusp.affiliation.countryChina
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryPolônia
hcfmusp.affiliation.countryTurquia
hcfmusp.affiliation.countryChile
hcfmusp.affiliation.countryRússia
hcfmusp.affiliation.countryTailândia
hcfmusp.affiliation.countryUcrânia
hcfmusp.affiliation.countryJapão
hcfmusp.affiliation.countryisolv
hcfmusp.affiliation.countryisocn
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisopl
hcfmusp.affiliation.countryisotr
hcfmusp.affiliation.countryisocl
hcfmusp.affiliation.countryisoru
hcfmusp.affiliation.countryisoth
hcfmusp.affiliation.countryisoua
hcfmusp.affiliation.countryisojp
hcfmusp.affiliation.countryisokr
hcfmusp.author.externalKUDABA, Iveta:Riga East Clin Univ, Latvian Oncol Ctr, Riga, Latvia
hcfmusp.author.externalWU, Yi-Long:Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
hcfmusp.author.externalLOPES, Gilberto:Univ Miami, Dept Med Oncol, Sylvester Comprehens Canc Ctr, Miami, FL USA
hcfmusp.author.externalKOWALSKI, Dariusz M.:Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lung Canc & Chest Tumours, Warsaw, Poland
hcfmusp.author.externalTURNA, Hande Z.:Istanbul Univ, Dept Internal Med, Cerrahpasa Med Fac, Istanbul, Turkey
hcfmusp.author.externalCAGLEVIC, Christian:Inst Oncol Fdn Arturo Lopez Perez, Canc Res Dept, Santiago, Chile
hcfmusp.author.externalZHANG, Li:Peking Union Med Coll Hosp, Beijing, Peoples R China
hcfmusp.author.externalKARASZEWSKA, Boguslawa:Przychodnia Lekarska KOMED, Konin, Poland
hcfmusp.author.externalLAKTIONOV, Konstantin K.:NN Blokhin Natl Med Res Ctr Oncol, Russian Federat NN Blokhin NMRCO, Minist Hlth, Fed State Budgetary Inst, Moscow, Russia
hcfmusp.author.externalSRIMUNINNIMIT, Vichien:Siriraj Hosp, Med, Bangkok, Thailand
hcfmusp.author.externalBONDARENKO, Igor:Dnipro State Med Univ, Oncol & Med Radiol Dept, Dnipro, Ukraine
hcfmusp.author.externalKUBOTA, Kaoru:Nippon Med Coll Hosp, Dept Pulm Med & Oncol, Tokyo, Japan
hcfmusp.author.externalMUKHERJEE, Rinee:Merck & Co Inc, Kenilworth, NJ USA
hcfmusp.author.externalLIN, Jianxin:Merck & Co Inc, Kenilworth, NJ USA
hcfmusp.author.externalSOUZA, Fabricio:Merck & Co Inc, Kenilworth, NJ USA
hcfmusp.author.externalMOK, Tony S. K.:Chinese Univ Hong Kong, State Key Lab Translat Oncol, Clin Oncol, Hong Kong, Peoples R China
hcfmusp.author.externalCHO, Byoung Chul:Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.description.beginpageA390
hcfmusp.description.endpageA390
hcfmusp.description.issuesuppl 2
hcfmusp.description.volume9
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000774877500352
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication.latestForDiscovery0df25c0f-1337-424e-b0f7-41d0fccb51fc
Arquivos